EyePoint, Inc. Payments to Acquire Marketable Securities
EyePoint, Inc. (EYPT) reported Payments to Acquire Marketable Securities of $9.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-05
- EyePoint, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $9.95M, a 74.76% decline year-over-year.
- EyePoint, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $148.84M, a 9.29% decline year-over-year.
- EyePoint, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $9.82M, a 80.06% decline year-over-year.
- EyePoint, Inc. payments to acquire marketable securities for fiscal 2025 was $252.02M, a 36.73% decline from fiscal 2024.
- EyePoint, Inc. payments to acquire marketable securities for fiscal 2024 was $398.30M, a 622.66% increase from fiscal 2023.
- EyePoint, Inc. payments to acquire marketable securities for fiscal 2023 was $55.12M, a 60.38% decline from fiscal 2022.
- EyePoint, Inc. payments to acquire marketable securities for fiscal 2022 was $139.12M, a 322.01% increase from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $9.95M 10-Q · filed 2026-08-05 | $158.78M derived: sum of 3 quarters · filed 2026-08-05 | $168.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $9.95M 10-Q · filed 2026-05-07 | $158.78M derived: sum of 2 quarters · filed 2026-05-07 | $168.60M derived: sum of 3 quarters · filed 2026-05-07 | $222.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $148.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $158.65M derived: sum of 2 quarters · filed 2026-03-05 | $212.60M derived: sum of 3 quarters · filed 2026-08-05 | $252.02M 10-K · filed 2026-03-05 |
| 2025-09-30 | $9.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $63.76M derived: sum of 2 quarters · filed 2026-08-05 | $103.19M 10-Q · filed 2025-11-06 | $267.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $53.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $93.37M 10-Q · filed 2026-08-05 | $257.45M derived: sum of 3 quarters · filed 2026-08-05 | $306.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $39.42M 10-Q · filed 2026-05-07 | $203.50M derived: sum of 2 quarters · filed 2026-05-07 | $252.73M derived: sum of 3 quarters · filed 2026-05-07 | $437.73M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $164.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $213.31M derived: sum of 2 quarters · filed 2026-03-05 | $398.30M derived: sum of 3 quarters · filed 2026-03-05 | $398.30M 10-K · filed 2026-03-05 |
| 2024-09-30 | $49.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $234.22M derived: sum of 2 quarters · filed 2025-11-06 | $234.22M 10-Q · filed 2025-11-06 | $283.49M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $185.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $185.00M 10-Q · filed 2025-08-07 | $234.26M derived: sum of 3 quarters · filed 2025-08-07 | $234.26M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $49.27M derived: sum of 2 quarters · filed 2025-05-08 | $49.27M derived: sum of 3 quarters · filed 2025-05-08 | $52.19M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $49.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $49.27M derived: sum of 2 quarters · filed 2025-03-06 | $52.19M derived: sum of 3 quarters · filed 2025-03-06 | $55.12M 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.92M derived: sum of 2 quarters · filed 2024-11-07 | $5.85M 10-Q · filed 2024-11-07 | $19.35M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.85M 10-Q · filed 2024-08-08 | $19.35M derived: sum of 3 quarters · filed 2024-08-08 | $52.88M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $2.93M 10-Q · filed 2024-05-09 | $16.43M derived: sum of 2 quarters · filed 2024-05-09 | $49.96M derived: sum of 3 quarters · filed 2024-05-09 | $79.75M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $47.03M derived: sum of 2 quarters · filed 2024-03-08 | $76.82M derived: sum of 3 quarters · filed 2024-03-08 | $139.12M 10-K · filed 2024-03-08 |
| 2022-09-30 | $33.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $63.32M derived: sum of 2 quarters · filed 2023-11-03 | $125.62M 10-Q · filed 2023-11-03 | $158.58M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $29.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $92.09M 10-Q · filed 2023-08-04 | $125.05M derived: sum of 3 quarters · filed 2023-08-04 | |
| 2022-03-31 | $62.29M 10-Q · filed 2023-05-04 | $95.26M derived: sum of 2 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $32.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $32.97M 10-K · filed 2023-03-10 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-04 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-14 | |||
| 2017-03-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $3.00M derived: sum of 2 quarters · filed 2017-05-08 | $5.05M 10-Q · filed 2017-05-08 | $12.33M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-12-31 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $5.05M 10-Q · filed 2017-02-09 | $12.33M derived: sum of 3 quarters · filed 2017-02-09 | $16.73M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-09-30 | $2.05M 10-Q · filed 2016-11-08 | $9.33M derived: sum of 2 quarters · filed 2016-11-08 | $13.73M derived: sum of 3 quarters · filed 2017-05-08 | $17.04M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-06-30 | $7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $11.67M derived: sum of 2 quarters · filed 2017-05-08 | $14.98M derived: sum of 3 quarters · filed 2017-05-08 | $17.52M 10-K · filed 2016-09-13 |
| 2016-03-31 | $4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $7.71M derived: sum of 2 quarters · filed 2017-05-08 | $10.24M 10-Q · filed 2017-05-08 | $11.79M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $5.84M 10-Q · filed 2017-02-09 | $7.39M derived: sum of 3 quarters · filed 2017-02-09 | $12.78M derived: sum of 4 quarters · filed 2017-02-09 |
| 2015-09-30 | $2.54M 10-Q · filed 2016-11-08 | $4.08M derived: sum of 2 quarters · filed 2016-11-08 | $9.47M derived: sum of 3 quarters · filed 2016-11-08 | $12.51M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-06-30 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $6.93M derived: sum of 2 quarters · filed 2016-09-13 | $9.97M derived: sum of 3 quarters · filed 2016-09-13 | $10.22M 10-K · filed 2016-09-13 |
| 2015-03-31 | $5.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-06 | $8.43M derived: sum of 2 quarters · filed 2016-05-06 | $8.68M 10-Q · filed 2016-05-06 | $8.93M derived: sum of 4 quarters · filed 2016-09-13 |
| 2014-12-31 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $3.29M 10-Q · filed 2016-02-09 | $3.54M derived: sum of 3 quarters · filed 2016-09-13 | $6.25M derived: sum of 4 quarters · filed 2016-09-13 |
| 2014-09-30 | $251.00K 10-Q · filed 2015-11-06 | $501.00K derived: sum of 2 quarters · filed 2016-09-13 | $3.21M derived: sum of 3 quarters · filed 2016-09-13 | |
| 2014-06-30 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $2.96M derived: sum of 2 quarters · filed 2016-09-13 | $2.96M 10-K · filed 2016-09-13 | |
| 2014-03-31 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08 | $2.71M 10-Q · filed 2015-05-08 | ||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-12 | |||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-10 | $3.17M derived: sum of 2 quarters · filed 2015-09-10 | $4.96M derived: sum of 3 quarters · filed 2015-09-10 | $7.76M 10-K · filed 2015-09-10 |
| 2013-03-31 | $3.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14 | $4.96M derived: sum of 2 quarters · filed 2014-05-14 | $7.76M 10-Q · filed 2014-05-14 | $10.91M derived: sum of 4 quarters · filed 2014-09-11 |
| 2012-12-31 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-12 | $4.58M 10-Q · filed 2014-02-12 | $7.74M derived: sum of 3 quarters · filed 2014-09-11 | $13.06M derived: sum of 4 quarters · filed 2014-09-11 |
| 2012-09-30 | $2.80M 10-Q · filed 2013-11-13 | $5.95M derived: sum of 2 quarters · filed 2014-09-11 | $11.28M derived: sum of 3 quarters · filed 2014-09-11 | $14.46M derived: sum of 4 quarters · filed 2014-09-11 |
| 2012-06-30 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | $8.48M derived: sum of 2 quarters · filed 2014-09-11 | $11.66M derived: sum of 3 quarters · filed 2014-09-11 | $15.39M 10-K · filed 2014-09-11 |
| 2012-03-31 | $5.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14 | $8.51M derived: sum of 2 quarters · filed 2013-05-14 | $12.24M 10-Q · filed 2013-05-14 | $17.27M derived: sum of 4 quarters · filed 2013-09-27 |
| 2011-12-31 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-08 | $6.92M 10-Q · filed 2013-02-08 | $11.95M derived: sum of 3 quarters · filed 2013-09-27 | $16.85M derived: sum of 4 quarters · filed 2013-09-27 |
| 2011-09-30 | $3.73M 10-Q · filed 2012-11-09 | $8.76M derived: sum of 2 quarters · filed 2013-09-27 | $13.67M derived: sum of 3 quarters · filed 2013-09-27 | $16.23M derived: sum of 4 quarters · filed 2013-09-27 |
| 2011-06-30 | $5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | $9.94M derived: sum of 2 quarters · filed 2013-09-27 | $12.50M derived: sum of 3 quarters · filed 2013-09-27 | $15.96M 10-K · filed 2013-09-27 |
| 2011-03-31 | $4.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | $7.47M derived: sum of 2 quarters · filed 2012-05-10 | $10.93M 10-Q · filed 2012-05-10 | |
| 2010-12-31 | $2.56M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-09 | $6.03M 10-Q · filed 2012-02-09 | ||
| 2010-09-30 | $3.47M 10-Q/A · filed 2011-11-09 | |||
| 2010-06-30 | $2.05M 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |